Concepedia

Amy Brideau-Andersen

AB

6

Publications

486

Citations

6

H-Index

2003

Active since

Affiliations

Allergan (United States)(Current)

AbbVie (United States)

University of California, Irvine

Amy Brideau-Andersen is an author at Allergan (United States) specializing in drug discovery, viral immunity, and viral polymerase structure.

Top concepts

Publications per year

2003–2023

6

Publications

6

Interference of hepatitis C virus RNA replication by short interfering RNAs

Sharookh B. Kapadia, Amy Brideau-Andersen, Francis V. Chisari · Proceedings of the National Academy of Sciences · 2003 · 394 citations · Full text

Directed evolution of gene-shuffled IFN-α molecules with activity profiles tailored for treatment of chronic viral diseases

Amy Brideau-Andersen, Xiaojian Huang, Siu-Chi Chang Sun et al. · Proceedings of the National Academy of Sciences · 2007 · 37 citations · Full text

, , +21

OnabotulinumtoxinA effects on trigeminal nociceptors

Ashley A Moore, Mariana Nelson, Christopher Wickware et al. · Cephalalgia · 2023 · 18 citations · Full text

Characterization of clostridium botulinum neurotoxin serotype A (BoNT/A) and fibroblast growth factor receptor interactions using novel receptor dimerization assay

Nicholas G. James, Shiazah Malik, Bethany J. Sanstrum et al. · Scientific Reports · 2021 · 15 citations · Full text

OnabotulinumtoxinA Displays Greater Biological Activity Compared to IncobotulinumtoxinA, Demonstrating Non-Interchangeability in Both In Vitro and In Vivo Assays

D. Rupp, Greg Nicholson, David Canty et al. · Toxins · 2020 · 12 citations · Full text

Rows per page

1–5 of 6